PRF Technologies Provides Year-End 2025 Business Update Highlighting Strategic Progress Across Healthcare and AI-Driven Solar Platforms
Publisher
Global
This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.
Read originalIn-platform summary, original article off-platform
This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.
Source route
Continue on prf-tech.com
Leave the platform to read the original full article on the publisher site.
Source: PainReform
Scope: Industry
Related coverage
More related coverage
Shionogi Announces Corporate Reorganization and Personnel Reassignment (Effective April 1, 2026)
OSAKA, Japan, February 13, 2026 - Shionogi & Co., Ltd. (Head Office: Osaka, Japan; President and CEO...
Mar.02.2026CorporateAnnouncement on Changes of the Board of Directors and Corporate Officers
Osaka, Japan, March 2, 2026 - Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President an...
Global Alliances: Structuring Successful Cross-Border Life Sciences Partnerships
Press releaseMar 29, 2026Novartis IgAN data in New England Journal of Medicine show Fabhalta® slowed kidney function decline by 49.3%Fabhalta lowered likelihood of progression to kidney failure by 43% in APPLAUSE-IgAN study140.7% of patients on Fabhalta demonstrated sustained reduction of protein in urine over two years1Fabhalta…
Fabhalta lowered likelihood of progression to kidney failure by 43% in APPLAUSE-IgAN study 1 40.7% o...